Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Davidson

Showing results (61-70 of 300) with videos related to

Pageof 30
Sort By:
Expert Review of Cardiovascular Therapy|March 20, 2004
Ezetimibe: a novel option for lowering cholesterolMichael H Davidson
Current Opinion in Lipidology|May 2, 2018
Clinical trialsMichael H Davidson
Expert Opinion on Pharmacotherapy|October 13, 2007
The use of colesevelam hydrochloride in the treatment of dyslipidemia: a reviewMichael H Davidson
The American Journal of Cardiology|February 20, 2007
Global risk management in patients with type 2 diabetes mellitusMichael H Davidson
The American Journal of Managed Care|November 23, 2006
Differences between clinical trial efficacy and real-world effectivenessMichael H Davidson
Arteriosclerosis, Thrombosis, and Vascular Biology|August 22, 2008
Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessmentMichael H Davidson
Clinical Cardiology|September 11, 2009
Apolipoprotein measurements: is more widespread use clinically indicated?Michael H Davidson
The American Journal of Cardiology|August 2, 2011
Cardiovascular effects of glucagonlike peptide-1 agonistsMichael H Davidson
Current Opinion in Lipidology|November 5, 2013
Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acidMichael H Davidson
Nature Reviews. Cardiology|September 11, 2013
Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolutionMichael H Davidson
Pageof 30

Showing results (61-70 of 300) with videos related to

Sort By:
Pageof 30
Expert Review of Cardiovascular Therapy|March 20, 2004
Ezetimibe: a novel option for lowering cholesterolMichael H Davidson
Current Opinion in Lipidology|May 2, 2018
Clinical trialsMichael H Davidson
Expert Opinion on Pharmacotherapy|October 13, 2007
The use of colesevelam hydrochloride in the treatment of dyslipidemia: a reviewMichael H Davidson
The American Journal of Cardiology|February 20, 2007
Global risk management in patients with type 2 diabetes mellitusMichael H Davidson
The American Journal of Managed Care|November 23, 2006
Differences between clinical trial efficacy and real-world effectivenessMichael H Davidson
Arteriosclerosis, Thrombosis, and Vascular Biology|August 22, 2008
Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessmentMichael H Davidson
Clinical Cardiology|September 11, 2009
Apolipoprotein measurements: is more widespread use clinically indicated?Michael H Davidson
The American Journal of Cardiology|August 2, 2011
Cardiovascular effects of glucagonlike peptide-1 agonistsMichael H Davidson
Current Opinion in Lipidology|November 5, 2013
Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acidMichael H Davidson
Nature Reviews. Cardiology|September 11, 2013
Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolutionMichael H Davidson
Pageof 30